Kopran Ltd.

View in App
254.90 -4.60 ▼-1.8%

26 April 2024, 04:02:40 PM
Volume: 265,657

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kopran.com
Market Cap 1,233.71 Cr.
Enterprise Value(EV) 1,335.58 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 8.37 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 30.56 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 94.84 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.70 Calculated using Price: 255.90
Dividend Yield 1.17 Period Ending 2023-03
No. of Shares Subscribed 4.82 Cr. 48,210,605 Shares
FaceValue 10
About Kopran Ltd.
The company was incorporated on April 26, 1958 as a private limited company under the name Kopran Chemical Company Pvt. Ltd. by Ramanlal V Shah Sevantilal, A Shah , Chimanlal G Sheth and Jivanalal M Shah. In 1972, the company's management was acquired by Chemo Pharma Laboratories Ltd and the Company's products were marketed by them.

Kopran Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Kopran Ltd. Performance

View details >>
1 Day
-1.77%
1 Week
-4.26%
1 Month
+0.65%
3 Month
-0.23%
6 Month
+30.99%
1 Year
+69.65%
2 Year
-5.51%
5 Year
+555.27%
10 Year
+749.67%

Kopran Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -43.06 12.19 17.71 15.21 15.34 11.74 28.34 18.19 6.29
Return on Capital Employed (%) -12.48 13.09 19.24 13.88 16.3 13.69 30.4 21.4 8.3
Return on Assets (%) -13.63 3.98 7.15 6.77 7.27 5.84 15.22 11.62 4.32

Kopran Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 99 109 125 145 168 190 245 426 439 441
Non Curr. Liab. 18 33 32 31 46 40 34 33 33 34
Curr. Liab. 158 122 136 136 135 140 161 152 177 202
Minority Int.
Equity & Liab. 275 264 293 312 349 370 439 611 650 678
Non Curr. Assets 105 110 114 118 142 148 162 196 251 271
Curr. Assets 170 154 180 194 208 223 277 415 399 408
Misc. Exp. not W/O
Total Assets 275 264 293 312 349 370 439 611 650 678

Kopran Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 326 296 310 313 358 360 492 478 551 577
Other Income 7 2 11 11 4 1 18 11 3 9
Total Income 332 299 320 324 362 360 510 488 554 586
Total Expenditure -294 -266 -274 -284 -312 -313 -410 -390 -499 -513
PBIDT 38 33 47 40 49 47 100 98 55 74
Interest -13 -13 -14 -9 -9 -9 -6 -5 -6 -8
Depreciation -10 -8 -8 -9 -9 -10 -10 -11 -13 -13
Taxation -5 -2 -8 -7 -22 -21 -9 -13
Exceptional Items -54 -1 -1
PAT -39 11 20 20 24 21 62 61 27 40
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -39 11 20 20 24 21 62 61 27 40
Adjusted EPS -10 2 5 5 6 5 14 13 6 8

Kopran Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 3 46 29 16 26 25 31 60 -33 34
Cash Fr. Inv. -9 -10 -9 -18 -11 -25 -13 -25 -84 -13
Cash Fr. Finan. 7 -37 -19 2 -15 -1 -18 -35 123 -20
Net Change 0 0 0 0 0 0 0 0 5 2
Cash & Cash Eqvt 1 1 1 1 0 0 1 1 6 7

Kopran Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 44.25 44.25 44.25 44.30 44.30 44.49 44.49 44.51 44.49
Public 55.75 55.75 55.75 55.70 55.70 55.51 55.51 55.49 55.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Kopran Ltd. Announcements

View details >>
Wed, 10 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Kopran Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Tue, 09 Apr 2024
Disclosure under SEBI Takeover Regulations
Kopran Limitedￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ
Mon, 08 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
Kopran Limited has informed the Exchange about Loss of share certificates

Kopran Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 5 Years High Increase in 5 Years

Kopran Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,506.55 -0.9%
Cipla Ltd. 113,471.29 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,252.10 +0.5%
Divi's Laboratories Ltd. 101,959.84 4,016.35 +4.5%
Zydus Lifesciences Ltd. 95,944.41 947.40 -0.4%
Mankind Pharma Ltd. 95,926.91 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,258.60 -2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.60 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,258.60 -2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.38 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,258.60 -2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,258.60 -2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,258.60 -2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,258.60 -2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,258.60 -2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,258.60 -2.0%

Kopran Ltd. FAQ's

What is Kopran share price?
Can I buy Kopran shares now?
What is the Dividend Yield of Kopran?
What is the Market Cap of Kopran?
What are the key metrics to analyse Kopran?
What is the 52 Week High and Low of Kopran?
What is the trend of Kopran share price?